Several classes of medications can push blood chloride above the normal range, a condition called hyperchloremia. The most frequent offender in hospital settings is ordinary intravenous saline, but drugs that interfere with the kidney’s ability to handle acid and bicarbonate, certain immunosuppressants, some antimicrobials, and even over-the-counter supplements can do it too. In one case, a medication does not actually raise chloride at all but tricks the lab analyzer into reporting a falsely high number.
Intravenous Saline Is the Most Common Culprit
Normal saline (0.9% sodium chloride) is the workhorse fluid in hospitals worldwide, yet it contains about 154 milliequivalents per liter of chloride, well above the roughly 100–106 range found in healthy blood. When large volumes are infused during surgery, trauma resuscitation, or treatment of dehydration, the chloride load overwhelms the kidneys’ ability to excrete the excess. Hypertonic saline solutions, which are even more concentrated, are routinely used in neurocritical care to control brain swelling and intracranial pressure. While these solutions are effective for that purpose, their high chloride content reliably causes hyperchloremia in the patients who receive them.
The problem is well recognized in intensive care units. A review of chloride management in critically ill patients noted that fluid resuscitation protocols, the choice between different fluid types, and individualized approaches form the core strategies for keeping chloride in check. In neurocritical care specifically, hyperchloremia has been called a “necessary evil” because the benefits of controlling intracranial pressure with chloride-rich fluids often outweigh the metabolic side effects.
The kidneys normally reabsorb about 99% of filtered chloride, which means a healthy kidney can handle modest chloride loads by simply letting more pass into the urine. But when fluid is poured in faster than the kidneys can adjust, or when kidney function is already compromised, blood chloride climbs. This is especially relevant in critically ill patients receiving liters of saline over hours or days.
Drugs That Disrupt Kidney Acid Handling
A large group of medications raise chloride indirectly by interfering with how the kidneys manage acid and bicarbonate. When bicarbonate is lost or not properly regenerated, chloride fills the gap in the blood’s electrical balance, producing what clinicians call hyperchloremic metabolic acidosis. Several distinct drug classes cause this through different mechanisms.
Carbonic Anhydrase Inhibitors
Acetazolamide, prescribed for glaucoma and altitude sickness, and zonisamide, used as an anti-seizure medication, both inhibit the enzyme carbonic anhydrase. This enzyme is essential for reclaiming bicarbonate in the kidney’s filtering units. When it is blocked, bicarbonate spills into the urine, blood bicarbonate drops, and chloride rises to compensate. Acetazolamide is probably the best-known example of a drug that causes this pattern, and the effect is dose-dependent and generally reversible once the medication is stopped.
Calcineurin Inhibitors
Cyclosporine and tacrolimus are immunosuppressants given to transplant recipients to prevent organ rejection. Both drugs can injure the kidney tubules and impair the kidney’s ability to excrete acid, producing a pattern of high potassium and high chloride alongside a drop in bicarbonate. One review described how cyclosporine-induced tubular injury decreases aldosterone activity and suppresses ammonium excretion, both of which contribute to the acidosis. Case series in solid organ transplant recipients have documented this pattern developing roughly two to five weeks after surgery, a timeframe that lines up with reaching steady-state drug levels.
The same pattern has been reported in bone marrow transplant recipients taking calcineurin inhibitors, where the acidosis can become serious enough to require treatment with bicarbonate supplements or dose adjustments.
Amphotericin B
This antifungal, used for serious systemic fungal infections, is notorious for kidney side effects. A study evaluating kidney function in 22 patients receiving amphotericin B found that all six patients tested during active treatment had defective renal acid excretion, even though none had developed outright systemic acidosis yet. The researchers concluded that incomplete renal tubular acidosis is a common but reversible complication of the drug. The mechanism involves direct damage to the distal kidney tubule, impairing its ability to secrete hydrogen ions into the urine.
Other Hospital Drugs That Affect the Tubules
A broader review of drug-induced acid-base problems identified several additional medications that can cause hyperchloremic acidosis through kidney tubule damage:
- Ifosfamide: a chemotherapy agent that can cause a generalized dysfunction of the proximal tubule, leading to bicarbonate wasting and chloride elevation.
- Aminoglycosides: antibiotics like gentamicin that are well-known for kidney toxicity and can impair proximal tubular function.
- Antiretrovirals: certain HIV medications, particularly tenofovir, can damage the proximal tubule in a similar fashion.
- Cisplatin and oxaliplatin: platinum-based chemotherapy drugs that cause tubular injury.
- NSAIDs: nonsteroidal anti-inflammatory drugs can reduce acid excretion in the distal tubule, particularly in patients who already have some degree of kidney impairment.
- Vitamin D (in excess): high-dose vitamin D has been linked to distal renal tubular acidosis.
These medications share a common thread: they damage or interfere with specific segments of the kidney tubule responsible for reclaiming bicarbonate or secreting acid. The loss of bicarbonate leaves a gap in the blood’s anion balance that chloride fills.
Cholestyramine
Cholestyramine is a bile-acid-binding resin prescribed mainly to lower cholesterol. It works by exchanging chloride ions for bile acids in the gut. The released chloride is then absorbed into the bloodstream, directly adding to the body’s chloride load. Case reports have documented severe hyperchloremic metabolic acidosis in patients taking cholestyramine, including both adults using it for high cholesterol and children receiving it for diarrhea management. The mechanism is straightforward: the drug is literally an anion exchange resin, and chloride is the anion it releases.
This side effect is more likely to cause trouble in patients with kidney disease who cannot efficiently excrete the extra chloride, or in anyone taking high doses for extended periods. Monitoring blood chemistry periodically during cholestyramine therapy helps catch the problem early.
Potassium Chloride and Other Chloride-Containing Supplements
Potassium chloride supplements, commonly prescribed to correct low potassium, deliver a substantial chloride load alongside the potassium. A study in patients with chronic kidney disease found that even short-term potassium chloride supplementation raised plasma chloride and lowered both bicarbonate and urine pH. The change was statistically clear and consistent across participants. In people with healthy kidneys, the extra chloride is usually handled without difficulty. But in patients whose kidneys are already struggling to maintain acid-base balance, even a seemingly modest chloride supplement can tip the scales.
The same principle applies to ammonium chloride, sometimes used as a urinary acidifier, and calcium chloride given intravenously. Any medication or supplement that delivers chloride directly into the body can raise blood chloride levels if the dose is large enough relative to the kidney’s excretory capacity.
When High Chloride Is Actually a Lab Error
Not every high chloride reading reflects a real increase in the body’s chloride. Salicylates, the drug class that includes aspirin, can interfere with the electrode used to measure chloride in many laboratory analyzers. At toxic salicylate levels, this interference can generate a markedly false elevation in the reported chloride concentration, a phenomenon called pseudohyperchloremia. The severity of the artifact depends on the salicylate level, the specific type of electrode, and how old the electrode is.
Pseudohyperchloremia matters clinically because it produces a confusingly small or even negative anion gap on lab results, which can send clinicians down the wrong diagnostic path. Recognizing that the patient has taken a large amount of aspirin or another salicylate-containing product is the key to catching this artifact. If the anion gap looks impossibly low and the patient has a history of salicylate use, the chloride number is probably wrong.
Why Elevated Chloride Matters
A reasonable follow-up question is whether high chloride is just a number on a lab slip or something that actually affects your health. The evidence points toward real physiological consequences, particularly for the kidneys.
Animal studies have shown that hyperchloremia causes the blood vessels within the kidney to constrict, reducing blood flow and the kidney’s filtering rate. One set of experiments demonstrated that chloride-induced vasoconstriction was specific to the kidney’s blood vessels and was made worse by prior salt depletion. A separate study found that hyperchloremia reduced the glomerular filtration rate by about 31% and kidney blood flow by about 36%, and that thromboxane, an inflammatory signaling molecule, played a role in driving the constriction.
In human patients, the clinical data aligns with these experimental findings. A study of patients with acute ischemic stroke found that those who developed hyperchloremia had roughly twice the risk of acute kidney injury compared to matched patients without hyperchloremia, and they spent about four extra days in the hospital. Separately, research in septic animals showed that hyperchloremic acidosis increased circulating levels of several inflammatory molecules, suggesting that high chloride may amplify the body’s inflammatory response during critical illness.
How Potassium-Sparing Diuretics and ACE Inhibitors Fit In
Potassium-sparing diuretics like spironolactone and amiloride, along with ACE inhibitors and angiotensin receptor blockers, do not dump chloride into the body the way saline does. Instead, they reduce the kidney’s secretion of potassium and hydrogen ions, which can indirectly lead to a hyperchloremic pattern, especially in patients with chronic kidney disease. The connection to chloride is through acid-base balance: when the kidney retains acid (hydrogen ions), bicarbonate falls and chloride fills the gap.
Research in chronic kidney disease patients has explored whether baseline chloride levels relative to sodium can predict who will develop dangerously high potassium after starting an ACE inhibitor or ARB. Patients who already have a low sodium-minus-chloride difference, which is a rough proxy for underlying metabolic acidosis, appear to be at higher risk. This finding underscores that the chloride story in these patients is often one piece of a larger acid-base puzzle rather than a standalone problem.
Balanced Fluids and Clinical Management
For the biggest source of drug-induced hyperchloremia, intravenous fluids, the most direct solution is switching to balanced crystalloid solutions like lactated Ringer’s or Plasma-Lyte. These fluids contain chloride concentrations much closer to normal blood levels and include buffering anions like lactate or acetate. Large randomized trials in critically ill patients have compared normal saline to balanced fluids, and the shift toward balanced solutions has become a major theme in intensive care medicine over the past decade.
For medications that cause hyperchloremia through kidney tubule effects, management depends on whether the drug can be stopped or the dose reduced. Transplant recipients on calcineurin inhibitors may need oral bicarbonate supplementation to counteract the acidosis, since stopping the immunosuppressant is usually not an option. Patients on acetazolamide can sometimes tolerate the mild acidosis if it is expected and monitored. For amphotericin B, the development of less toxic formulations (liposomal versions) has reduced but not eliminated the kidney side effects.
Monitoring is the common denominator across all these scenarios. Regular checks of a basic metabolic panel, which includes chloride, bicarbonate, sodium, and potassium, let clinicians catch a rising chloride level before it causes symptoms or kidney damage. For patients on multiple medications that each nudge chloride upward, the cumulative effect can be greater than any single drug would produce alone, making the periodic lab check all the more important.
Medications That Get Blamed but Probably Should Not
Lithium, widely used for bipolar disorder, is sometimes mentioned in the same breath as drugs that cause electrolyte problems. Lithium certainly affects the kidneys, particularly their ability to concentrate urine, leading to excessive urination and thirst. However, its primary electrolyte effect is on sodium and water balance, not on chloride specifically. While any drug that alters kidney function can theoretically shift chloride handling, lithium is not a well-documented direct cause of hyperchloremia in the way that the medications above are.
Similarly, loop diuretics like furosemide are associated with chloride loss (hypochloremia) rather than chloride gain, because they block the sodium-potassium-chloride cotransporter in the kidney and cause chloride to be excreted. Patients sometimes confuse the two directions: loop diuretics lower chloride, while potassium-sparing diuretics and aldosterone antagonists can raise it. Knowing which direction a diuretic pushes chloride helps avoid unnecessary alarm when lab results come back.
The Role of Kidney Function in Drug-Induced Hyperchloremia
Across nearly every medication class discussed here, the severity of chloride elevation depends heavily on how well the kidneys are working. Healthy kidneys have enormous capacity to excrete extra chloride. The kidney filters chloride freely at the glomerulus and reabsorbs about 99% of it through a series of transporters along the nephron. When a chloride load arrives, the kidney can reduce that reabsorption and allow more chloride into the urine. This safety valve means that a person with normal kidney function who takes a potassium chloride supplement or receives a moderate amount of saline will usually handle the extra chloride without their blood level budging much.
Patients with chronic kidney disease lose this buffer. Their reduced filtering capacity means chloride accumulates more easily, and many of the tubular mechanisms for adjusting chloride reabsorption are already impaired. This is why drug-induced hyperchloremia tends to be a clinical problem primarily in hospitalized patients, those with kidney disease, and transplant recipients on nephrotoxic immunosuppressants, rather than in the general population taking an occasional anti-inflammatory or potassium supplement. If you have been told your kidney function is reduced and you are taking any of the medications listed above, periodic electrolyte monitoring is worth discussing with your doctor.